DE69929051T2 - Lanthanidchelate der cinoxacin und ihre verwendung als biomolekulare probe - Google Patents

Lanthanidchelate der cinoxacin und ihre verwendung als biomolekulare probe Download PDF

Info

Publication number
DE69929051T2
DE69929051T2 DE69929051T DE69929051T DE69929051T2 DE 69929051 T2 DE69929051 T2 DE 69929051T2 DE 69929051 T DE69929051 T DE 69929051T DE 69929051 T DE69929051 T DE 69929051T DE 69929051 T2 DE69929051 T2 DE 69929051T2
Authority
DE
Germany
Prior art keywords
group
cinoxacin
minutes
lanthanide
hplc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69929051T
Other languages
German (de)
English (en)
Other versions
DE69929051D1 (de
Inventor
Colin Andrew Harlow LEACH
Keith James Millan Harlow MOORE
Steven James Harlow STANWAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE69929051D1 publication Critical patent/DE69929051D1/de
Publication of DE69929051T2 publication Critical patent/DE69929051T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76Metal complexes of amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/83Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
DE69929051T 1998-06-25 1999-06-18 Lanthanidchelate der cinoxacin und ihre verwendung als biomolekulare probe Expired - Fee Related DE69929051T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9813776.3A GB9813776D0 (en) 1998-06-25 1998-06-25 Novel compounds
GB9813776 1998-06-25
PCT/EP1999/004277 WO1999066780A2 (en) 1998-06-25 1999-06-18 Cinoxacin lanthanide chelates and their use as biomolecular probes

Publications (2)

Publication Number Publication Date
DE69929051D1 DE69929051D1 (de) 2006-01-26
DE69929051T2 true DE69929051T2 (de) 2006-07-13

Family

ID=10834399

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929051T Expired - Fee Related DE69929051T2 (de) 1998-06-25 1999-06-18 Lanthanidchelate der cinoxacin und ihre verwendung als biomolekulare probe

Country Status (8)

Country Link
US (1) US6441167B1 (US06441167-20020827-C00004.png)
EP (1) EP1090007B1 (US06441167-20020827-C00004.png)
JP (1) JP2002518413A (US06441167-20020827-C00004.png)
CA (1) CA2335610A1 (US06441167-20020827-C00004.png)
DE (1) DE69929051T2 (US06441167-20020827-C00004.png)
ES (1) ES2253899T3 (US06441167-20020827-C00004.png)
GB (1) GB9813776D0 (US06441167-20020827-C00004.png)
WO (1) WO1999066780A2 (US06441167-20020827-C00004.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6740756B1 (en) 1998-07-07 2004-05-25 Smithkline Beecham Corporation Fluorescent lanthanide chelates
WO2000001663A1 (en) * 1998-07-07 2000-01-13 Smithkline Beecham Corporation Novel fluorescent lanthanide chelates
AUPP856399A0 (en) * 1999-02-08 1999-03-04 Australian Membrane And Biotechnology Research Institute Improved compounds for protein binding
JP2006022123A (ja) * 2002-06-27 2006-01-26 Ajinomoto Co Inc キレート剤
CN107954893A (zh) * 2017-11-28 2018-04-24 兰州纬寰生物科技有限公司 邻氨基苯甲酰胺衍生物及制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE207098C (de) 1908-03-06 1909-02-16 Koppers Gmbh Heinrich Verfahren zur Leuchtgasherstellung durch Destillation von Steinkohlen und Beimengung eines billigeren Gases zu dem Steinkohlengas.
NL147145B (nl) * 1969-02-04 1975-09-15 Lilly Co Eli Werkwijze ter bereiding van preparaten met antimicrobiele werking.
US4379929A (en) * 1981-03-19 1983-04-12 Eli Lilly And Company 4(1H)-Oxocinnoline-3-carboxylic acid derivatives
DD207098A3 (de) * 1981-12-22 1984-02-15 Schmidt Hans Joerg Verfahren zur herstellung von 1-alkyl-6,7-methylendioxy-4(1h)-oxo-cinnolin-3-carbonsaeuren
ES2133312T3 (es) 1991-12-05 1999-09-16 Wallac Oy Quelatos de lantanidos luminiscentes.
US5622821A (en) * 1994-06-29 1997-04-22 The Regents Of The University Of California Luminescent lanthanide chelates and methods of use

Also Published As

Publication number Publication date
CA2335610A1 (en) 1999-12-29
WO1999066780A3 (en) 2000-02-03
JP2002518413A (ja) 2002-06-25
US6441167B1 (en) 2002-08-27
ES2253899T3 (es) 2006-06-01
EP1090007B1 (en) 2005-12-21
EP1090007A2 (en) 2001-04-11
DE69929051D1 (de) 2006-01-26
WO1999066780A2 (en) 1999-12-29
GB9813776D0 (en) 1998-08-26

Similar Documents

Publication Publication Date Title
DE69923859T2 (de) Porphyrin-Verbindungen, ihre Konjugate und Testmethoden basierend auf der Verwendung besagter Konjugate
EP0371262B1 (de) Neue Digoxigenin-Derivate und ihre Verwendung
EP0209875B1 (de) Resorufin-Derivate sowie Verfahren zu deren Herstellung
DE69535554T2 (de) Lumineszente lanthanidenchelate und verfahren zu ihrer verwendung
EP1732935A2 (de) Lanthanoidchelate und ihre anwendung in der bioanalytik
Oswald et al. Red laser-induced fluorescence energy transfer in an immunosystem
DE69818044T2 (de) Chemilumineszente energietransfer-konjugate und ihre verwendung als markierungsmittel in bindungstests
DE3033691A1 (de) An ein substrat gebundene diamintriessigsaeuren und ihre chelate
DE2952498A1 (de) Spezifische bindungsuntersuchungsmethode zum nachweisen eines liganden in einem fluessigen medium und reagentien zur durchfuehrung der methode
EP0618231A1 (de) Immunologisch aktive Konjugate und ein Verfahren zu ihrer Herstellung
WO2002041001A1 (de) Farbstoffpaare für fluoreszenz-resonanz-energie-transfer (fret) messungen
EP0747447B1 (de) Neue Oxazinfarbstoffe und ihre Verwendung als Fluoreszenzmarker
EP0632810B1 (de) Neues biotinylierungsreagenz
EP0697021B1 (de) Photoaktivierbare biotinderivate und deren einsatz zum entstören von immunoassays
CA2336904A1 (en) Novel fluorescent lanthanide chelates
EP1054039B1 (de) Neue Fluoreszenzfarbstoffe und ihre Verwendung als Fluoreszenzmarker
DE69929051T2 (de) Lanthanidchelate der cinoxacin und ihre verwendung als biomolekulare probe
US6740756B1 (en) Fluorescent lanthanide chelates
EP1317511B1 (de) Oxazinderivate
DE60214709T2 (de) Verfahren zur Erhöhung der Hydrophilie von Fluoreszenzmarker-Verbindungen
DE69720589T2 (de) Carbodiimidverbindungen die eine fluoreszierende Gruppe enthalten
EP1308728A2 (de) Verfahren und Verbindungen zur Fluoreszenzmarkierung von Biomolekülen und Polymerpartikeln
DE60016323T2 (de) Neue Pyrylium Verbindung, Verfahren zu ihrer Herstellung, Nucleinsäure-Färbemittel und markierte Nucleinsäure
WO2004092174A1 (de) Pyrrolopyrrole als fluoreszente marker für biomoleküle und sphärische partikel
EP1440315B1 (de) Nachweis humaner auto-antikörper

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee